PlainRecalls
FDA Devices Moderate Class II Ongoing

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Reported: January 14, 2026 Initiated: December 5, 2025 #Z-1019-2026

Product Description

Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300

Reason for Recall

The affected lots show a decline in performance over time, which may lead to false-negative results.

Details

Recalling Firm
Meridian Bioscience Inc
Units Affected
211 units
Distribution
US Nationwide distribution and the OUS country of Italy.
Location
Cincinnati, OH

Frequently Asked Questions

What product was recalled?
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300. Recalled by Meridian Bioscience Inc. Units affected: 211 units.
Why was this product recalled?
The affected lots show a decline in performance over time, which may lead to false-negative results.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 14, 2026. Severity: Moderate. Recall number: Z-1019-2026.